Page last updated: 2024-08-16

timolol and Skin Neoplasms

timolol has been researched along with Skin Neoplasms in 71 studies

Research

Studies (71)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (1.41)	18.2507
2000's	0 (0.00)	29.6817
2010's	45 (63.38)	24.3611
2020's	25 (35.21)	2.80

Authors

Authors	Studies
Chang, Q; Chen, Z; Hu, G; Hu, L; Li, Q; Long, J	1
Colmant, C; Powell, J	1
McLean, TW; Pahl, KS	1
Cai, Y; Chen, C; Gong, X; Kang, B; Li, W; Xu, Y; Yu, Q; Zheng, H	1
Cai, B; Chen, X; Huang, H; Wang, B; Yu, J	1
Gong, ZC; Li, CX; Li, H; Ling, B; Zhou, YC	1
Hildebrand, GD; Sipkova, Z	1
Lai, W; Luo, H; Zhu, H	1
Davis, RF; Paul, SP	1
Cavalli, R; Chelleri, C; Fossali, EF; Galeone, C; Gelmetti, C; Milani, GP; Monzani, NA	1
Cao, Y; Li, L; Liu, D; Lv, X; Sun, L; Tian, L; Wang, C; Zhao, W	1
Abagge, KT; Mussato, LP; Oliveira de Carvalho, VO; Petterle, RR; Sakai, LSM; Sandri, CO	1
de la Cruz, E; Galván, C; Lozano-Masdemont, B; Marinero, S; Pérez-Tato, B; Polimón, I	1
Artzi, O; Bar-Ilan, E; Friedman, O; Koren, A; Mashiah, J; Zur, E	1
Chang, L; Chang, S; Chen, Q; Chen, Z; Han, Y; Lin, X; Ma, G; Qiu, Y; Ying, H; Yu, Z	1
Chang, L; Chang, SJ; Chen, QY; Chen, ZA; Lin, XX; Ma, G; Qiu, YJ; Ying, HR; Zhang, Y	1
Alfano, R; Argenziano, G; Babino, G; Briatico, G; Fulgione, E; Gambardella, A; Giorgio, CMR; Licata, G	1
Lan, SJ; Liu, M; Liu, SS; Rong, L; Yang, TY; Zhang, JY	1
Ganatra, B; Gandhi, R; Kelly, A; Natkunarajah, J	1
Alsumait, A; Blei, F; Bradley, F; Cotton, C; Covelli, I; Fernández Faith, E; Frieden, IJ; Gupta, D; Harfmann, K; Hunt, R; Moore-Clingenpeel, M; Nguyen, H; Pope, E; Shah, S; Streicher, JL; Tollefson, M; Witman, PM	1
Baselga, E; Bernabeu-Wittel, J; Gich, I; Montserrat-García, MT; Muñoz-Garza, FZ; Puig, L; Ríos, M; Roé-Crespo, E	1
Brambilla, L; Maronese, CA; Tourlaki, A	1
Bhatia, R; Chandrasekaran, D; Durgapal, P; Gupta, V; Hazarika, N; Kishore, S	1
Rodríguez Bandera, AL; Sebaratnam, DF; Wargon, O; Wong, LF	1
Foong, AYW; Koh, MJ; Ng, MSY; Ng, SS; Tay, YK	1
Bates, B; Drolet, BA; Keuter, T; Mueller, K; Schilter, K; Seefeldt, M; Yu, J	1
Fernández-Redondo, V; Pousa-Martínez, M; Sainz-Gaspar, L; Suárez-Peñaranda, JM; Vázquez-Veiga, H	1
Admani, S; Borok, J; Friedlander, SF; Gangar, P; Proudfoot, J	1
Braue, A; Chap, S; Robinson, AJ; Scardamaglia, L; Varigos, GA; Vu, M	1
Abdelmaksoud, A; Filoni, A; Giudice, G; Vestita, M	2
Arevalo-Rodriguez, I; Baselga, E; Beltran, S; Giraldo, L; Novoa, M; Pardo-Hernandez, H; Shahbaz, A	2
Costa, RD; Prindaville, B; Rork, JF; Wiss, K	1
Drolet, BA; M Hill, I; Stefanko, N	1
Almebayadh, M	1
Cuenca-Barrales, C; Espadafor-López, B; Ruiz-Villaverde, R; Salvador-Rodriguez, L	1
Li, L; Ma, L; Qiu, L; Wei, L; Zhang, B; Zhang, N	1
Antaya, RJ; Craiglow, BG	1
Chen, H; Hu, X; Jin, Y; Lin, X; Ma, G; Qiu, Y; Yang, J	1
Adams, S; Chan, H; McKay, C; Wargon, O	1
Kazandjieva, J; Semkova, K	1
Beroukhim, K; Rotunda, AM	1
Chung, HY; Jang, YH; Kim, DW; Lee, SJ; Lee, WJ; Park, KH	1
Cohen, ER; Landy, DC; Ovadia, SA; Thaller, SR; Yang, EY	1
Hu, L; Huang, HZ; Li, W; Li, X; Lin, XX	1
La Placa, M; Neri, I; Patrizi, A; Virdi, A	1
Chang, L; Chen, H; Chen, M; Jin, Y; Lin, X; Ma, G; Qiu, Y; Wang, T; Yang, J	1
Bordel-Gómez, MT; Cardeñoso-Álvarez, ME; Fraile-Alonso, MC; Meseguer-Yebra, C; Pérez-Losada, ME; Sánchez-Estella, J	1
Cao, RY; Sun, NN; Tong, S; Wang, XK; Xu, DP; Xue, L	1
Garg, VK; Sarkar, R; Sethi, S	1
Bayart, CB; Brandling-Bennett, HA	1
Cheng, C; Gong, H; Li, G; Li, YX; Wang, XK; Xu, DP	1
Fruge, JH; Massengale, WT; Rouhana, HF	1
Li, G; Sun, NN; Tong, S; Wang, XK; Xu, DP; Xue, L	1
Ge, J; Yuan, W; Zhang, L; Zhao, H; Zheng, J	1
Boos, MD; Castelo-Soccio, L	1
Baoli, S; Chunfen, L; Jiachuan, X; Linjun, Y; Qixing, X	1
Bayart, C; Desai, R; Gill, K; Golden, A; Raimer, P; Tamburro, J	1
Alcántara-Reifs, CM; Garnacho-Saucedo, GM; Salido-Vallejo, R; Vélez García-Nieto, A	1
Adams, D; Baselga, E; Drolet, B; Feigenbaum, D; Frieden, I; Garzon, MC; Holland, K; Horii, K; Lauren, C; Lucky, A; Mathes, E; McCuaig, C; Morel, KD; Newell, B; Nopper, A; Pope, E; Powell, J; Püttgen, K; Savva, Y; Siegel, D; Song, W	1
Cheng, CE; Friedlander, SF	1
Bly, RA; Parikh, SR; Perkins, J	1
Belloni Fortina, A; Causin, F; De Corti, F; Fontana, E	1
Fan, XD; Huo, R; Jiang, CH; Lei, SR; Liu, SH; Qin, ZP; Wang, XK; Wang, XY; Yang, YW; Zhao, JH; Zheng, JW; Zhou, DK	1
Dombi, TM; Huang, K; Jessen, B; Kwok, KK; Tressler, CS; Wirostko, BM; Wiseman, RL	1
Krol, A; Lofgren, S	1
Gonzalez, ME; Orlow, SJ; Tlougan, BE	1
Frieden, IJ; Tollefson, MM	1
Chen, H; Chen, XD; Hu, XJ; Jin, YB; Lin, XX; Ma, G; Qiu, YJ; Ye, XX	1
Imami, N; Khawly, JA; Shields, MB	1

Reviews

16 review(s) available for timolol and Skin Neoplasms

Article	Year
Medical Management of Infantile Hemangiomas: An Update. Paediatric drugs, 2022, Volume: 24, Issue:1 Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Hemangioma; Humans; Infant; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2022
Infantile Hemangioma: A Current Review. Journal of pediatric hematology/oncology, 2022, 03-01, Volume: 44, Issue:2 Topics: Adrenergic beta-Antagonists; Child; Hemangioma; Humans; Infant; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2022
Comparison of the efficacy and safety of lasers, topical timolol, and combination therapy for the treatment of infantile hemangioma: A meta-analysis of 10 studies. Dermatologic therapy, 2022, Volume: 35, Issue:12 Topics: Administration, Topical; Adrenergic beta-Antagonists; Combined Modality Therapy; Hemangioma; Humans; Infant; Lasers; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2022
Residual Lesions After Pharmacological and Dye-Laser Treatment of Infantile Hemangiomas: Critical Review of 432 Cases. Lasers in surgery and medicine, 2020, Volume: 52, Issue:7 Topics: Hemangioma, Capillary; Humans; Infant; Lasers, Dye; Observational Studies as Topic; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2020
Infantile hemangioma. Part 2: Management. Journal of the American Academy of Dermatology, 2021, Volume: 85, Issue:6 Topics: Adrenergic beta-Antagonists; COVID-19; Hemangioma, Capillary; Humans; Infant; Nevus; Pandemics; Propranolol; SARS-CoV-2; Skin Neoplasms; Timolol; Treatment Outcome	2021
Interventions for infantile haemangiomas of the skin. The Cochrane database of systematic reviews, 2018, 04-18, Volume: 4 Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Antineoplastic Agents; Bleomycin; Child, Preschool; Hemangioma, Capillary; Humans; Infant; Lasers, Dye; Methylprednisolone; Photochemotherapy; Prednisolone; Propranolol; Radiotherapy; Randomized Controlled Trials as Topic; Remission Induction; Skin Neoplasms; Timolol	2018
Interventions for infantile haemangiomas of the skin: abridged Cochrane systematic review and GRADE assessments. The British journal of dermatology, 2019, Volume: 180, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Adrenergic beta-Antagonists; Bradycardia; GRADE Approach; Hemangioma; Humans; Hypotension; Placebos; Propranolol; Randomized Controlled Trials as Topic; Skin Neoplasms; Timolol	2019
Successful treatment of ulcerated infantile hemangioma with brimonidine-timolol cream: 2 cases report and review of the literature. The Journal of dermatological treatment, 2020, Volume: 31, Issue:4 Topics: Administration, Topical; Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Antagonists; Brimonidine Tartrate; Drug Combinations; Female; Hemangioma; Humans; Infant; Ointments; Skin Neoplasms; Skin Ulcer; Timolol	2020
Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches. Paediatric drugs, 2013, Volume: 15, Issue:2 Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Aminoquinolines; Hemangioma; Humans; Imiquimod; Infant; Off-Label Use; Propranolol; Skin Neoplasms; Timolol	2013
Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis. Annals of plastic surgery, 2015, Volume: 74, Issue:2 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Hemangioma, Capillary; Humans; Infant; Injections, Intralesional; Models, Statistical; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2015
Beta-blockers for childhood vascular tumors. Current opinion in pediatrics, 2015, Volume: 27, Issue:4 Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Atenolol; Child, Preschool; Facial Neoplasms; Humans; Infant; Neoplastic Syndromes, Hereditary; Neurocutaneous Syndromes; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome; Vascular Neoplasms	2015
Beta blocker treatment for infantile hemangiomas. Dermatology online journal, 2015, Jul-15, Volume: 21, Issue:7 Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hemangioma, Capillary; Humans; Infant; Male; Nadolol; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2015
Infantile hemangiomas, complications and treatments. Seminars in cutaneous medicine and surgery, 2016, Volume: 35, Issue:3 Topics: Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Airway Obstruction; Drug Therapy, Combination; Esthetics; Facial Neoplasms; Hemangioma; Humans; Infant; Laser Therapy; Propranolol; Skin Neoplasms; Skin Ulcer; Timolol	2016
Can topical beta-blockers reduce the size of superficial infantile hemangiomas of the head and neck? The Laryngoscope, 2017, Volume: 127, Issue:1 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Humans; Practice Guidelines as Topic; Skin Neoplasms; Timolol	2017
Lack of evidence for a link between latanoprost use and malignant melanoma: an analysis of safety databases and a review of the literature. The British journal of ophthalmology, 2011, Volume: 95, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Child; Child, Preschool; Databases, Factual; Drug Combinations; Evidence-Based Medicine; Eye Neoplasms; Female; Humans; Latanoprost; Male; Melanoma; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Skin Neoplasms; Timolol; Young Adult	2011
New therapies in pediatric dermatology. Current opinion in pediatrics, 2011, Volume: 23, Issue:4 Topics: Adrenergic beta-Antagonists; Child; Dermatitis, Atopic; Epidermolysis Bullosa Dystrophica; Etanercept; Hemangioma; Humans; Immunoglobulin G; Immunosuppressive Agents; Pediatrics; Psoriasis; Receptors, Tumor Necrosis Factor; Skin Diseases; Skin Neoplasms; Tacrolimus; Timolol; Ultraviolet Therapy; Vitamin D; Vitamins	2011

Trials

8 trial(s) available for timolol and Skin Neoplasms

Article	Year
The effect of 0.5% topical timolol cream on regression of superficial infantile haemangioma in the involuting phase: a prospective, randomized, self-controlled study. European journal of dermatology : EJD, 2020, Oct-01, Volume: 30, Issue:5 Topics: Antineoplastic Agents; Child, Preschool; Dermatologic Agents; Female; Hemangioma; Humans; Infant; Male; Prospective Studies; Skin Cream; Skin Neoplasms; Timolol; Treatment Outcome	2020
Comparison of the efficacy between topical timolol and pulsed dye laser in the treatment of ulcerated infantile haemangiomas: a randomized controlled study. Journal of the European Academy of Dermatology and Venereology : JEADV, 2021, Volume: 35, Issue:4 Topics: Administration, Topical; Hemangioma; Hemangioma, Capillary; Humans; Infant; Lasers, Dye; Skin Neoplasms; Timolol; Treatment Outcome; Ulcer	2021
Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial. JAMA dermatology, 2021, 05-01, Volume: 157, Issue:5 Topics: Administration, Topical; Adrenergic beta-Antagonists; Double-Blind Method; Drug Administration Schedule; Female; Hemangioma, Capillary; Humans; Infant; Infant, Newborn; Male; Pilot Projects; Prospective Studies; Skin Neoplasms; Timolol; Treatment Outcome	2021
Safety and efficacy of topical timolol treatment of infantile haemangioma: a prospective trial. The British journal of dermatology, 2018, Volume: 178, Issue:1 Topics: Administration, Topical; Antineoplastic Agents; Drug Administration Schedule; Facial Neoplasms; Female; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Male; Prospective Studies; Scalp; Skin Neoplasms; Timolol; Treatment Outcome	2018
RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds. Pediatrics, 2013, Volume: 131, Issue:6 Topics: Double-Blind Method; Female; Gels; Hemangioma; Humans; Infant; Male; Skin Neoplasms; Timolol; Treatment Outcome	2013
Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma. Dermatology (Basel, Switzerland), 2015, Volume: 230, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Extremities; Facial Neoplasms; Female; Hemangioma, Capillary; Humans; Imiquimod; Infant; Male; Neoplastic Syndromes, Hereditary; Non-Randomized Controlled Trials as Topic; Ointments; Ophthalmic Solutions; Skin Neoplasms; Timolol; Torso	2015
Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions. The Journal of craniofacial surgery, 2016, Volume: 27, Issue:1 Topics: Administration, Oral; Administration, Topical; Antineoplastic Agents; Drug Therapy, Combination; Facial Neoplasms; Female; Follow-Up Studies; Hemangioma; Humans; Infant; Male; Mouth Neoplasms; Propranolol; Prospective Studies; Safety; Skin Neoplasms; Timolol; Treatment Outcome; Ultrasonography; Visual Analog Scale	2016
Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study. Scientific reports, 2016, Jan-28, Volume: 6 Topics: Administration, Oral; Administration, Topical; Aftercare; Female; Hemangioma; Humans; Infant; Infant, Newborn; Male; Propranolol; Retrospective Studies; Skin Neoplasms; Time Factors; Timolol	2016

Other Studies

47 other study(ies) available for timolol and Skin Neoplasms

Article	Year
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents. Bioorganic & medicinal chemistry, 2020, 05-01, Volume: 28, Issue:9 Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Docking Simulation; Molecular Structure; Propanols; Skin Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured	2020
Predictors of treatment responses of superficial infantile hemangiomas to topical timolol. Dermatologic therapy, 2022, Volume: 35, Issue:11 Topics: Administration, Topical; Adrenergic beta-Antagonists; Child, Preschool; Hemangioma; Humans; Infant; Prospective Studies; Skin Neoplasms; Timolol; Treatment Outcome	2022
Application of topical betaxolol to cure superficial infantile hemangioma: A pilot study. Pediatrics international : official journal of the Japan Pediatric Society, 2022, Volume: 64, Issue:1 Topics: Adrenergic beta-Antagonists; Betaxolol; Child; Hemangioma; Hemangioma, Capillary; Humans; Infant; Pilot Projects; Skin Neoplasms; Timolol; Treatment Outcome	2022
Successful Late Treatment of Orbital Infantile Haemangiomas in Two Teenagers with Topical Transcutaneous Timolol Maleate 0.5% Alone. Klinische Monatsblatter fur Augenheilkunde, 2022, Volume: 239, Issue:10 Topics: Administration, Topical; Adolescent; Adrenergic beta-Antagonists; Child; Exophthalmos; Female; Hemangioma, Capillary; Humans; Infant; Skin Neoplasms; Timolol; Treatment Outcome	2022
Efficacy of timolol in the treatment of facial hemangioma and its effect on the proliferation and apoptosis of hemangioma stem cells. Cellular and molecular biology (Noisy-le-Grand, France), 2023, Oct-31, Volume: 69, Issue:10 Topics: Cell Proliferation; Child; Hemangioma; Humans; Infant; Skin Neoplasms; Timolol; Treatment Outcome	2023
Infantile haemangioma: topical timolol gel may be safer in premature babies. British journal of hospital medicine (London, England : 2005), 2019, Aug-02, Volume: 80, Issue:8 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Humans; Infant, Newborn; Infant, Premature, Diseases; Skin Neoplasms; Timolol	2019
Fractional 2940-nm Er:YAG laser-assisted drug delivery of timolol maleate for the treatment of deep infantile hemangioma. The Journal of dermatological treatment, 2021, Volume: 32, Issue:8 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Humans; Infant; Lasers, Solid-State; Pharmaceutical Preparations; Skin Neoplasms; Timolol; Treatment Outcome	2021
Colorimetric analysis of images in the follow-up of infantile hemangiomas. Pediatric dermatology, 2020, Volume: 37, Issue:4 Topics: Adrenergic beta-Antagonists; Colorimetry; Female; Follow-Up Studies; Hemangioma; Hemangioma, Capillary; Humans; Infant; Skin Neoplasms; Timolol; Treatment Outcome	2020
Allergic contact dermatitis caused by timolol eyedrop application for classic Kaposi sarcoma. The Australasian journal of dermatology, 2020, Volume: 61, Issue:4 Topics: Administration, Topical; Aged; Dermatitis, Allergic Contact; Humans; Male; Sarcoma, Kaposi; Skin Neoplasms; Timolol	2020
Enhanced Percutaneous Delivery of Beta-Blockers Using Thermal Resurfacing Drug Delivery System for Topical Treatment of Infantile Hemangiomas. Dermatology (Basel, Switzerland), 2020, Volume: 236, Issue:6 Topics: Administration, Topical; Adrenergic beta-Antagonists; Drug Delivery Systems; Female; Hemangioma, Capillary; Humans; Hyperthermia, Induced; Infant; Male; Propranolol; Retrospective Studies; Skin Neoplasms; Timolol	2020
Comparison between propranolol 2% cream versus timolol 0.5% gel for the treatment of Kaposi sarcoma. International journal of dermatology, 2021, Volume: 60, Issue:5 Topics: Adrenergic beta-Antagonists; Humans; Propranolol; Sarcoma, Kaposi; Skin Neoplasms; Timolol	2021
Topical Timolol Combined Intralesional Injection of Diprospan in the Treatment of Elevated Localized Mixed Infantile Hemangiomas and a Discussion for Proper Timing for Injection. The Journal of craniofacial surgery, 2021, May-01, Volume: 32, Issue:3 Topics: Administration, Topical; Adrenergic beta-Antagonists; Betamethasone; Drug Combinations; Hemangioma; Humans; Infant; Injections, Intralesional; Skin Neoplasms; Timolol; Treatment Outcome	2021
Treatment of eruptive angiokeratomas of the flanks with topical and oral beta-blockers. Clinical and experimental dermatology, 2021, Volume: 46, Issue:6 Topics: Abdomen; Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Angiokeratoma; Atenolol; Female; Humans; Skin Neoplasms; Timolol; Young Adult	2021
Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile Hemangioma. JAMA dermatology, 2021, 05-01, Volume: 157, Issue:5 Topics: Adrenergic beta-Antagonists; Age Factors; Bandages; Combined Modality Therapy; Female; Hemangioma, Capillary; Humans; Infant; Lasers, Dye; Low-Level Light Therapy; Male; Prognosis; Retrospective Studies; Skin Neoplasms; Skin Ulcer; Timolol; Treatment Outcome; Wound Healing	2021
Successful treatment of conjunctival classic Kaposi's sarcoma with topical timolol. Italian journal of dermatology and venereology, 2021, Volume: 156, Issue:5 Topics: Conjunctiva; Conjunctival Neoplasms; Humans; Sarcoma, Kaposi; Skin Neoplasms; Timolol	2021
Treatment of Posttraumatic Reactive Angioendotheliomatosis With Topical Timolol Maleate. JAMA dermatology, 2021, 08-01, Volume: 157, Issue:8 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioendothelioma; Humans; Skin Neoplasms; Timolol	2021
Comparison of Two Formulations of Topical Timolol for the Treatment of Infantile Hemangiomas. Pediatric dermatology, 2017, Volume: 34, Issue:4 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Humans; Infant; Ophthalmic Solutions; Retrospective Studies; Skin Neoplasms; Timolol; Treatment Outcome	2017
Variability of Delivery of Timolol for the Treatment of Infantile Hemangiomas. Pediatric dermatology, 2017, Volume: 34, Issue:4 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Humans; Pharmaceutical Solutions; Skin Neoplasms; Timolol	2017
Topical timolol for treatment of penile Kaposi sarcoma in HIV-negative patient. Dermatologic therapy, 2017, Volume: 30, Issue:5 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Aged; Humans; Male; Penile Neoplasms; Sarcoma, Kaposi; Skin Neoplasms; Timolol; Treatment Outcome	2017
Treatment of cutaneous iatrogenic Kaposi sarcoma with topical timolol. The Australasian journal of dermatology, 2017, Volume: 58, Issue:3 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Humans; Iatrogenic Disease; Leg; Male; Middle Aged; Sarcoma, Kaposi; Skin Neoplasms; Timolol; Treatment Outcome	2017
Topical timolol for Kaposi sarcoma: An innovation. The Australasian journal of dermatology, 2018, Volume: 59, Issue:4 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Humans; Sarcoma, Kaposi; Skin Neoplasms; Timolol	2018
Response to "Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas". Pediatric dermatology, 2018, Volume: 35, Issue:5 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Hemangioma, Capillary; Humans; Infant; Skin Neoplasms; Timolol; Treatment Outcome	2018
Comment on "Doing the math: A simple approach to topical timolol dosing for infantile hemangiomas". Pediatric dermatology, 2018, Volume: 35, Issue:5 Topics: Administration, Topical; Adrenergic beta-Antagonists; Hemangioma; Hemangioma, Capillary; Humans; Infant; Skin Neoplasms; Timolol; Treatment Outcome	2018
Iatrogenic Kaposi's Sarcoma Successfully Treated with Topical Timolol. Actas dermo-sifiliograficas, 2020, Volume: 111, Issue:2 Topics: Administration, Topical; Aged; Female; Humans; Iatrogenic Disease; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Timolol	2020
Topical timolol maleate for treatment of tufted angioma. The Journal of dermatology, 2019, Volume: 46, Issue:11 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Biopsy; Child, Preschool; Female; Hemangioma; Humans; Ophthalmic Solutions; Skin; Skin Neoplasms; Timolol; Treatment Outcome	2019
Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study. Clinical and experimental dermatology, 2013, Volume: 38, Issue:8 Topics: Administration, Topical; Adrenergic beta-Antagonists; Aminoquinolines; Antineoplastic Agents; Female; Hemangioma; Humans; Imiquimod; Infant; Male; Retrospective Studies; Skin Neoplasms; Timolol	2013
Rapid complete regression of an early infantile hemangioma with topical timolol gel. International journal of dermatology, 2014, Volume: 53, Issue:2 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Gels; Head and Neck Neoplasms; Hemangioma, Capillary; Humans; Infant; Male; Neoplastic Syndromes, Hereditary; Scalp; Skin Neoplasms; Timolol; Treatment Outcome	2014
Topical 0.5% timolol heals a recalcitrant irradiated surgical scalp wound. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2014, Volume: 40, Issue:8 Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Male; Mohs Surgery; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Scalp; Skin Neoplasms; Timolol; Wound Healing	2014
Topical timolol maleate 0.5% for infantile hemangioma; it's effectiveness and/or adjunctive pulsed dye laser - single center experience of 102 cases in Korea. The Journal of dermatological treatment, 2015, Volume: 26, Issue:4 Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Female; Hemangioma; Humans; Infant; Lasers, Dye; Male; Republic of Korea; Retrospective Studies; Skin Neoplasms; Timolol; Treatment Outcome	2015
A perineal infantile haemangioma presenting as early ulcerations. Archives of disease in childhood. Fetal and neonatal edition, 2015, Volume: 100, Issue:5 Topics: Bandages, Hydrocolloid; Female; Hemangioma; Humans; Infant, Newborn; Perineum; Skin Neoplasms; Skin Ulcer; Timolol	2015
A prospective self-controlled study of topical timolol 0.5% cream for large superficial infantile hemangiomas. The Journal of dermatology, 2015, Volume: 42, Issue:4 Topics: Administration, Topical; Adrenergic beta-Antagonists; Female; Hemangioma; Humans; Infant; Male; Prospective Studies; Skin Cream; Skin Neoplasms; Timolol	2015
Successful treatment of classic Kaposi sarcoma with topical timolol: report of two cases. The British journal of dermatology, 2015, Volume: 173, Issue:3 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Foot Diseases; Humans; Leg; Male; Sarcoma, Kaposi; Skin Neoplasms; Timolol; Treatment Outcome	2015
Topical timolol maleate for superficial infantile hemangiomas: an observational study. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2015, Volume: 73, Issue:6 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Blood Glucose; Blood Pressure; Female; Follow-Up Studies; Head and Neck Neoplasms; Heart Rate; Hemangioma; Humans; Infant; Male; Photography; Remission Induction; Safety; Skin Neoplasms; Timolol; Treatment Outcome	2015
Topical timolol in nasal tip hemangioma: a viable alternative to systemic therapy. International journal of dermatology, 2015, Volume: 54, Issue:6 Topics: Administration, Topical; Female; Hemangioma; Humans; Infant; Nose Neoplasms; Skin Neoplasms; Timolol	2015
Evaluation of the efficacy and safety of propranolol, timolol maleate, and the combination of the two, in the treatment of superficial infantile haemangiomas. The British journal of oral & maxillofacial surgery, 2015, Volume: 53, Issue:9 Topics: Adrenergic beta-Antagonists; Drug Combinations; Hemangioma; Humans; Propranolol; Prospective Studies; Skin Neoplasms; Timolol; Treatment Outcome	2015
Experience with topical timolol maleate for the treatment of ulcerated infantile hemangiomas (IH). Journal of the American Academy of Dermatology, 2016, Volume: 74, Issue:3 Topics: Administration, Topical; Female; Gels; Hemangioma; Humans; Infant; Male; Retrospective Studies; Skin Neoplasms; Skin Ulcer; Timolol	2016
[A clinical study of Timolol Maleate Eye Drops for the treatment of superficial infantile hemangiomas]. Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery, 2015, Volume: 31, Issue:6 Topics: Administration, Topical; Adrenergic beta-Antagonists; Child; Hemangioma; Humans; Ophthalmic Solutions; Skin Neoplasms; Timolol; Treatment Outcome; Watchful Waiting	2015
Brimonidine Toxicity Secondary to Topical Use for an Ulcerated Hemangioma. Pediatric dermatology, 2016, Volume: 33, Issue:4 Topics: Administration, Topical; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Apnea; Brimonidine Tartrate; Female; Hemangioma, Capillary; Humans; Hypothermia; Infant; Ophthalmic Solutions; Respiration, Artificial; Respiratory Distress Syndrome, Newborn; Skin Neoplasms; Skin Ulcer; Timolol	2016
Classic Kaposi's sarcoma treated with topical 0.5% timolol gel. Dermatologic therapy, 2016, Volume: 29, Issue:5 Topics: Administration, Cutaneous; Aged, 80 and over; Antineoplastic Agents; Gels; Humans; Male; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Timolol; Treatment Outcome; Ultrasonography, Doppler, Color	2016
Topical Timolol Maleate Treatment of Infantile Hemangiomas. Pediatrics, 2016, Volume: 138, Issue:3 Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Cohort Studies; Female; Hemangioma; Humans; Infant; Infant, Newborn; Male; Off-Label Use; Propranolol; Retrospective Studies; Skin Neoplasms; Timolol; Visual Analog Scale	2016
Classic and HIV-related Kaposi sarcoma treated with 0.1% topical timolol gel. Journal of the American Academy of Dermatology, 2017, Volume: 76, Issue:1 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Aged; Antiretroviral Therapy, Highly Active; Female; Gels; HIV Infections; Humans; Male; Middle Aged; Sarcoma, Kaposi; Skin Neoplasms; Timolol	2017
Phace syndrome: is timolol gel a chance for treatment? Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:7 Topics: Abnormalities, Multiple; Administration, Topical; Arteries; Brain; Cranial Fossa, Posterior; Eye Abnormalities; Gels; Heart Defects, Congenital; Hemangioma; Humans; Infant; Phenotype; Skin Neoplasms; Syndrome; Timolol	2017
[Chinese expert consensus on the use of topical timolol maleate treatment of infantile hemangiomas]. Shanghai kou qiang yi xue = Shanghai journal of stomatology, 2016, Volume: 25, Issue:6 Topics: Administration, Topical; Adrenergic beta-Antagonists; Asian People; Consensus; Expert Testimony; Hemangioma; Humans; Infant; Propranolol; Skin Neoplasms; Timolol; Treatment Outcome	2016
Abortive segmental perineal hemangioma. Dermatology online journal, 2011, Oct-15, Volume: 17, Issue:10 Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Biomarkers, Tumor; Female; Glucose Transporter Type 1; Hemangioma; Humans; Infant; Perineum; Skin Neoplasms; Skin Ulcer; Timolol	2011
Early growth of infantile hemangiomas: what parents' photographs tell us. Pediatrics, 2012, Volume: 130, Issue:2 Topics: Adrenal Cortex Hormones; Age Factors; Diseases in Twins; Facial Neoplasms; Female; Hemangioma; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Lasers, Dye; Male; Nonlinear Dynamics; Photography; Propranolol; Referral and Consultation; Skin; Skin Neoplasms; Timolol; Treatment Outcome	2012
[Topical timolol in the treatment of periocular superficial infantile hemangiomas: a prospective study]. Zhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery, 2012, Volume: 28, Issue:3 Topics: Administration, Topical; Angiogenesis Inhibitors; China; Facial Neoplasms; Hemangioma; Hemangioma, Capillary; Humans; Infant; Prospective Studies; Skin Neoplasms; Timolol; Treatment Outcome	2012
Glaucoma associated with the nevus of Ota. Archives of ophthalmology (Chicago, Ill. : 1960), 1995, Volume: 113, Issue:9 Topics: Anterior Eye Segment; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Nevus of Ota; Ophthalmic Solutions; Optic Disk; Sclera; Skin Neoplasms; Timolol	1995